Bahrain announced that it had approved the emergency use of the Pfizer-BioNTech vaccine.
Highlight
- Bahrain has so far registered more than 87,000 new cases of coronavirus
- Britain said on Wednesday that it approved the Covid-19 vaccine for general use.
- UK plans to launch the vaccine next week
Manama, Bahrain:
Bahrain announced on Friday that it had approved the emergency use of Pfizer-BioNTech’s coronavirus vaccine, making it the second country after Great Britain to give the drug the green light.
“The approval of the Pfizer / BioNTech vaccine will add an additional important layer to the kingdom’s national Covid-19 response,” said Mariam al-Jalahma, executive director of the National Health Regulatory Authority, according to a statement released by the News Agency. Bahrain official. (BNA).
Manama did not specify when the launch of the vaccine by US pharmaceutical giant Pfizer and its German partner BioNTech would begin.
Britain said on Wednesday that it approved the Covid-19 vaccine for general use, with plans to start rolling it out next week.
In November, the small Gulf kingdom of Bahrain approved the use of China’s Sinopharm vaccine in front-line healthcare workers.
So far, Bahrain has recorded more than 87,000 new coronavirus cases, including 341 deaths.
“This authorization is a goal that we have been working towards since we first declared that science will win,” said Lindsey Dietschi, Pfizer’s representative in the Gulf, according to BNA.
Britain insisted on Friday that its first global approval of the Pfizer-BioNTech coronavirus vaccine met all safety standards, striving to assuage any public unrest after US and European officials questioned the swift process.
Companies have been racing to find a vaccine against the coronavirus, which has killed more than 1.5 million people and infected more than 65 million since it emerged in China in December last year.
.
